PharmaResearch Co., Ltd.
KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2001 and listed on KOSDAQ in 2015, PharmaResearch is a medical device company. It produces pharmaceuticals (Placentex, Rejuvinex, Zadaxin, Reentox), medical devices (HA fillers Cleviel and Rejuviel, PN-type Rejuran and Conjuran), and Rejuran-branded cosmetics (Healer, Clinic, and Derma Healer lines). Revenue is split 58.6% medical devices, 24.6% cosmetics, 15.4% pharmaceuticals, and 1.4% other, manufactured at Gangneung Plant 1 and 2 and subsidiary PharmaResearch Bio's dedicated botulinum toxin facility.
Products & technology
- PlacentexPDRN pharmaceutical
- RejuvinexPDRN pharmaceutical
- Zadaxinimmune enhancer
- Reentoxbotulinum toxin
- Clevielfacial aesthetic HA filler
- Rejuvielfacial aesthetic HA filler
- RejuranPN-type facial aesthetic injection
- ConjuranPN-type intra-articular knee injection
Regulatory approvals
data.go.kr19 Korean MFDS drug approvals · 2000–2025 / 43 Korean MFDS device approvals · 1999–2026
- MFDSDressing, occlusive, hydrogel2026-08-21Product approval · Class 2제인 26-4774 호
- MFDSGraft/prosthesis, biomaterial2026-08-20Product approval · Class 4제허 26-637 호
- MFDSDressing, fluid-impermeable film2026-05-04Product approval · Class 2제인 26-4393 호
- MFDSGraft/prosthesis, biomaterial2026-03-06Product approval · Class 4제허 26-180 호
- MFDSDressing, fluid-impermeable film2026-01-28Product approval · Class 2제인 26-4088 호
- MFDSDressing, fluid-impermeable film2025-08-27Product approval · Class 2제인 25-4792 호
- MFDS drugTeriment Injection(Teriparatide)2025-07-17Drug · Prescription · Approval202501822
- MFDSGraft/prosthesis2024-12-03Product approval · Class 4제허 24-853 호
- MFDSGraft/prosthesis, biomaterial2024-11-04Product approval · Class 4제허 24-767 호
- MFDSGraft/prosthesis2024-11-04Product approval · Class 4제허 24-766 호
- MFDSDressing, fluid-impermeable film2024-07-25Product approval · Class 2제인 24-720 호
- MFDSGraft/prosthesis, biomaterial2024-01-25Product approval · Class 4제허 24-65 호
Show 50 more
- MFDSGraft/prosthesis, biomaterial2023-02-06Product approval · Class 4제허 23-81 호
- MFDSGraft/prosthesis, biomaterial2022-11-18Product approval · Class 4제허 22-777 호
- MFDS drugPR-cholecalciferol inj2021-10-13Drug · Prescription · Notification202106881
- MFDS drugPR-Tramadol Hydrochloride Inj.Revoked2021-08-31Drug · Prescription · Notification202106253
- MFDS drugPR-Diclofenac Sodium Inj.Revoked2021-08-30Drug · Prescription · Notification202106241
- MFDSDressing, fluid-impermeable film2021-08-24Product approval · Class 2제인 21-4736 호
- MFDS drugPR-magnesium sulfate heptahydrate Inj. 100mgRevoked2021-08-18Drug · Prescription · Notification202106007
- MFDS drugPR-thioctic acid Inj. 5mgRevoked2021-08-11Drug · Prescription · Notification202105901
- MFDSGraft/prosthesis, biomaterial2021-07-23Product approval · Class 4제허 21-629 호
- MFDS drugPR-ascorbic acid Inj. 500mgRevoked2021-07-13Drug · Prescription · Notification202105322
- MFDS drugPR-fursultiamine injRevoked2021-03-25Drug · Prescription · Notification202102613
- MFDSDressing, adhesion barrier2021-03-03Product approval · Class 3제허 21-162 호
- MFDS drugNew-ARTI Inj.2020-03-16Drug · Prescription · Notification202001796
- MFDSDressing, fluid-impermeable filmRevoked2019-10-07Product approval · Class 2제인 19-4830 호
- MFDSGraft/prosthesis, biomaterial2019-06-12Product approval · Class 4제허 19-366 호
- MFDSGraft/prosthesis, biomaterial2017-10-25Product approval · Class 4제허 17-814 호
- MFDSGraft/prosthesis, biomaterial2017-05-29Product approval · Class 4제허 17-353 호
- MFDSGraft/prosthesis, biomaterial2017-05-10Product approval · Class 4수허 17-227 호
- MFDSGraft/prosthesis, biomaterial2016-11-11Product approval · Class 4제허 16-826 호
- MFDSGraft/prosthesis, biomaterial2016-03-24Product approval · Class 4제허 16-217 호
- MFDS drugRe-an Eye Drops (Polydeoxyribonucleotide sodium) (single use)2015-06-26Drug · OTC · Approval201504166
- MFDSGraft/prosthesis, biomaterial2015-01-20Product approval · Class 4제허 15-83 호
- MFDS drugRejuvenex Inj.(Polydeoxyribonucleotide sodium)2015-01-07Drug · Prescription · Approval201500071
- MFDS drugRejuvenex Cream(Polydeoxyribonucleotide sodium)2014-12-05Drug · OTC · Notification201405771
- MFDS drugPR-Purified Water2014-11-12Drug · OTC · Notification201405289
- MFDSGraft/prosthesis, biomaterial2014-04-09Product approval · Class 4제허 14-825 호
- MFDSGraft/prosthesis, biomaterial2014-01-07Product approval · Class 4제허 14-64 호
- MFDS drugLaennec PO(Human Placenta Hydrolysate)2013-11-13Drug · OTC · Approval201310120
- MFDSGraft/prosthesis, biomaterial2013-11-07Product approval · Class 4제허 13-1891 호
- MFDSPolydioxanone suture2013-10-24Product approval · Class 4제허 13-1799 호
- MFDSThread for facial tissue fixation, absorbable or non-absorbableRevoked2009-12-03Product approval · Class 4수허 09-1257 호
- MFDS drugPLACENTEX INJ2008-09-04Drug · Prescription · Approval200809246
- MFDS drugDuocaine cream2008-01-30Drug · Prescription · Notification200801307
- MFDS drugJBP Plamon Inj.(Human Placenta Extract)2007-07-26Drug · Prescription · Approval200708605
- MFDS drugVitafant Inj. 50(Fursultiamine Hydrochloride)Revoked2007-04-30Drug · Prescription · Notification200704948
- MFDSNebulizing system, non-heatedRevoked2007-04-06Product approval · Class 2수허 07-301 호
- MFDSNebulizing system, non-heatedRevoked2007-04-06Product approval · Class 2수허 07-300 호
- MFDS혈압계Revoked2004-05-11Product approval · Class 2수허 04-619 호
- MFDS의료용흡입기Revoked2003-06-10Product approval · Class 2수허 03-700 호
- MFDS의료용흡인기Revoked2002-08-05Product approval · Class 2수허 02-864 호
- MFDS혈압계Revoked2002-06-17Product approval · Class 2수허 02-673 호
- MFDS의료용흡입기Revoked2001-11-16Product approval · Class 2수허 01-1384 호
- MFDS의료용흡입기Revoked2001-11-16Product approval · Class 2수허 01-1385 호
- MFDS의료용흡입기Revoked2001-11-16Product approval · Class 2수허 01-1386 호
- MFDS의료용흡입기Revoked2001-11-15Product approval · Class 2수허 01-1372 호
- MFDS개인용저주파자극기Revoked2001-11-15Product approval · Class 2수허 01-1373 호
- MFDSMarker, surgical, internalRevoked2001-11-05Product approval · Class 2수허 01-1304 호
- MFDS혈압계Revoked2001-10-24Product approval · Class 2수허 01-1263 호
- MFDS drugZadaxin Inj2000-10-18Drug · Prescription · Approval200009072
- MFDS이식형스태플 [2]Revoked1999-10-11Product approval · Class 1수신 99-3776 호
AI reads
MAA server logs · IP-verifiedSomeone asked an AI a question, and it fetched this page live to answer.
Collected for later use. Not a signal of interest.
- OpenAIChatGPT-Useranswer1
- OpenAIOAI-SearchBot2
Measured since Aug 25, 2026 · 1 AI engines · last read Aug 26, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.
KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.
KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.
Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.
Founded and listed on the KOSDAQ in 2016, BNC Korea is a biohealthcare company specializing in HA fillers, botulinum toxin, and dermo-cosmetics.
KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.
Founded in 2003 and KOSDAQ-listed in 2021, BioPlus develops HA-based bio medical devices and biopharmaceuticals using its proprietary MDM Technology platform.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.
KOSDAQ-listed medical device company manufacturing synthetic bioresorbable suture yarn and dental root canal filling materials.
Wonbiogen Co.,Ltd., established September 2018, listed on KOSDAQ in December 2018, manufactures wound dressings and moist wound dressings.
Founded 1986, KONEX-listed since 2022, BASKHANBIOPharma makes drugs and medical devices for use before and after surgery.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition